Create your own free news widgets.

A new vaccine is being tested that could help prevent breast cancer from recurring in some women.

Vaccinating women against the human papillomavirus may prevent some forms of breast cancer and save tens of thousands of lives each year, new Australian research suggests.

Like many women, Teri did her research before making the decision to undergo breast augmentation. As a health-conscious mother seeking a better fit in her clothes, she was dissatisfied with the current breast implant choices of saline for safety or silicone gel for a more natural look, yet with bothersome potential risks.

Abstract: Human milk has evolved to provide the most appropriate nutritional and immunological support for newborn infants. In some situations, however, an individual mother is unable to meet the needs of her baby, for a variable length of time. In this situation donor milk, provided by a human milk bank, might be a better alternative than infant formula. There is evidence, particularly for preterm infants, that donor breast milk is better tolerated and carries a lower risk of necrotizing enterocolitis. Infection - particularly with viruses such as cytomegalovirus and HIV - may be transmitted in breast milk. This is a potential risk for any baby being breast-fed, but the risk can be avoided by pasteurization (heat treatment) of donor milk. Banked breast milk on a 'per-litre' basis is more expensive than infant formula; however, if a range of short- and long-term health outcomes are measured it may turn out to be cost-effective overall. Human milk banking is widespread around the world,

The ASCO Cancer Foundation, with the support of The Breast Cancer Research Foundation (BCRF), has created the Comparative Effectiveness Research Professorship (CERP) in Breast Cancer. This five-year grant award will provide flexible funding to an outstanding researcher who has made and will continue to make significant contributions in breast cancer research. The grant totals $500,000 and will be paid in 5 annual increments of $100,000 to the recipient's institution.

One in eight women will be diagnosed with breast cancer in her lifetime. Other than skin cancer, breast cancer is the most common type of cancer among women in the United States.

Breast cancer detection rates and sensitivity were higher, but so were false-positive rates, among mammography centers that offered clinical breast examination in addition to mammography, according to new study published online August 31 in the Journal of the National Cancer Institute. There is controversy about whether adding clinical breast examination to mammography improves the accuracy of breast screening. To address this, Anna M. Chiarelli, Ph.D.

Elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein in human breast cancer are associated with unfavorable prognosis and progressive stages of disease. Researchers writing in the open access journal BMC Cancer found increased expression of GLI1 in samples taken from more advanced and less survivable tumors. Edgar Dahl led a team of researchers from RWTH Aachen's University hospital who sought to evaluate whether GLI1 could represent a new prognostic marker in breast cancer treatment. He said, 'GLI1, a mediator of the so-called 'hedgehog' signaling pathway, has previously been implicated in the development of different human tumor entities. We've found a positive, significant association between overexpression of GLI1 a...

A recent study published in the Journal of Cancer Epidemiology has reinforced the correlation between being overweight, smoking and breast cancer. What makes this study unique is how test subjects were not diagnosed for BRCA1 and BRCA2 gene mutations, which predispose women to breast cancer. Instead, women with such gene mutations were excluded to allow researchers to concentrate on lifestyle factors such as smoking, exercise, nutrition and weight.

According to recent research from the United States, 'A diagnosis of metastatic breast cancer (BC) forces patients and providers to make difficult treatment decisions. To pilot test a decision aid (DA) for advanced BC. Pretest, posttest study.' 'Two academic cancer centers in Boston, Massachusetts. Fifty patients diagnosed with advanced BC. A patient DA that consisted of a 30-minute DVD and booklet. Patients were surveyed at baseline, after the intervention, and at 3 months. included use and acceptability of DA, distress, treatment goals, and preference for and actual participation in decisions. Physicians were surveyed at baseline and 3 months. included treatment goals, assessment of patients' experience with treatments, and patients' p...